News

CYCLOPES Trial Design and Rationale Published CERC is pleased to announce the publication of the design and rationale of the CYCLOPES Trial. The article details the scientific background, objectives, and study design of CYCLOPES, study, providing transparency on the trial’s methodological approach...

CERC is proud to share that TARGET FIRST and SELUTION DeNovo , both conducted with CERC, have been selected among the Top 10 studies in interventional cardiology in 2025 by the European Heart Journal. CERC is proud to share that TARGET FIRST and SELUTION DeNovo, both conducted with CERC, have been...

We are proud to share that the ALL WOMEN study has successfully reached its enrollment goal, and patient inclusion is now completed. Thank you to everyone involved for your strong commitment and teamwork. The next focus is data completion for primary endpoint communications. Learn more about the ALL...

Several CERC members attended the High Tech Cardio Congress in Marseille, a leading international event dedicated to innovation in cardiovascular medicine. CERC members Antoinette Neylon, Thomas Cuisset, Philippe Garot, and Didier Tchétché were present at the congress and actively participated in...

CERC is proud to support the publication of clinical trial results, working closely with investigators and sponsors to ensure high-quality scientific output and visibility in leading peer-reviewed journals. In 2025, CERC-supported studies resulted in 15 publications in major international journals...

The ABILITY Diabetes Global study has now been officially published in The Lancet, marking an important milestone for this large international clinical trial. The study was conducted under the scientific leadership of Mount Sinai and sponsored by Concept Medical, with the active involvement of a...

CERC will be present at PCR London Valves 2025, from 16 to 18 November in London. As a specialized cardiovascular CRO, CERC partners with leading innovators to transform ideas into successful clinical outcomes, from concept to completion, worldwide. Our team will be on site to share CERC’s expertise...

Major milestone in interventional cardiology! At TCT2025, Prof. Christian Spaulding presented the 12-month results of the landmark SELUTION DeNovo trial. The study demonstrated that a treatment strategy using SELUTION SLR™ Drug-Eluting Balloon with provisional stenting when needed, was non-inferior...

CERC is proud to share that the ABILITY DIABETES GLOBAL Trial has been accepted for publication in The Lancet. Conducted under the leadership of Dr. Roxana Mehran, this study reflects a successful collaboration between Mount Sinai and CERC as CRO.

CERC (Cardiovascular European Research Center) was proud to take part in AICT AsiaPCR 2025 in Singapore this weekend. The congress opened with an impressive live educational case on left main PCI, featuring several members of the CERC Asia (Cardiovascular European Research Center Asia) Board...